* Shattuck Labs Inc reported a quarterly adjusted loss of 33 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -65 cents. The mean expectation of four analysts for the quarter was for a loss of 42 cents per share. Wall Street expected results to range from -49 cents to -35 cents per share.
* Revenue rose 336.9% to $3.00 million from a year ago; analysts expected $652.25 thousand.
* Shattuck Labs Inc's reported EPS for the quarter was a loss of 33 cents.
* The company reported a quarterly loss of $16.68 million.
* Shattuck Labs Inc shares had fallen by 65.0% this quarter and lost 82.9% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by about 6.2% in the last three months.
* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology & medical research peer group is also "hold"
Wall Street's median 12-month price target for Shattuck Labs Inc is $2.00 This summary was machine generated from LSEG data November 14 at 02:15 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.42 -0.33 Beat
Jun. 30 2024 -0.41 -0.42 Missed
Mar. 31 2024 -0.45 -0.37 Beat
Dec. 31 2023 -0.57 -0.41 Beat
Comments